Myasthenia gravis (MG) and amyotrophic lateral sclerosis (ALS) are neuromuscular disorders that may share certain symptoms but have vastly different pathophysiologies, treatments, and outcomes.
INTRODUCTION
The aim of this chapter is to provide guidelines to the clinician for evaluating a patient who presents with suspected myasthenia gravis (MG) or amyotrophic lateral sclerosis (ALS). Clinically speaking, MG and ALS have distinct clinical features, but there are also occasional commonalities in their presentations, and these two disorders may, therefore, coexist in the differential diagnosis of a particular patient. As the treatments and prognoses are vastly different, it is obviously desirable to secure the diagnosis as early in the course of the disease as possible. This chapter will review the presenting symptoms and characteristic clinical signs of MG and ALS and provide distinguishing features of the two diseases when both are included in the initial differential diagnosis. Possible pitfalls in the diagnosis of both disorders will be highlighted. In general, ALS and MG can be readily diagnosed based on a thorough clinical evaluation, which is then supported by appropriate diagnostic laboratory and imaging studies. The complete differential diagnosis of ALS and MG will be covered in subsequent chapters.
MYASTHENIA GRAVIS
MG produces symptomatic weakness that predominates in certain muscle groups and typically fluctuates in response to effort and rest. The diagnosis of MG is primarily based on the clinical history and examination findings demonstrating this distinctive pattern of weakness. Confirmation of the clinical diagnosis may be obtained using pharmacologic, immunologic, and electrophysiologic tests, which are described in a subsequent chapter.
Clinical Diagnosis
The clinical hallmark of MG is the presence of fatigable muscle weakness. It is useful to distinguish fatigable muscle weakness from general fatigue or exhaustion. Patients with fluctuating fatigable muscle weakness due to MG will describe weakness in a specific group of muscles that is brought on by activity and improves with rest. In contrast, patients with general fatigue or exhaustion due to any number of causes will typically report all-over weakness, tiredness, or lack of energy. Patients with MG may have symptoms and signs only after exertion or at the end of the day. This may result in little detectable objective weakness at the time of examination, often delaying the diagnosis. Maneuvers that fatigue specific muscle groups can be very useful in eliciting signs of weakness in patients with MG because patients with generalized fatigue or malaise do not typically display true muscle weakness with these maneuvers (Table 1-1).
Characteristic clinical symptoms. Initial symptoms involve the ocular muscles in up to 85% of patients with MG (Grob et al, 2008) , and these patients will report ptosis, intermittent diplopia, or both. A majority of these patients (approximately 80%) will subsequently develop generalized MG. Occasionally, patients will report blurred vision rather than diplopia, often prompting them to change their eyeglasses in an attempt to correct the problem. Ptosis may not be noticed (up to 20) ptosis will note that the severity of the eyelid droop varies during the course of the day, often worsening after exercise, reading, while driving, and with exposure to direct sunlight. Nearly all patients with MG will develop ocular manifestations at some point during the course of their illness. Up to 20% of patients with MG may have prominent oropharyngeal symptoms early in the disease course, including dysarthria, dysphagia, and difficulty chewing (Grob, 1953) . This percentage is higher in anti-musclespecific receptor tyrosine kinase (MuSK) antibody positive MG. (The clinical phenotype of anti-MuSK-positive MG is discussed in the subsequent chapter.) At times, oropharyngeal symptoms may be present with minimal associated ocular symptoms, particularly in lateonset and anti-MuSK-positive disease. Weakness of palatal muscles may result in a nasal quality to the voice. Speech may become slurred with prolonged talking, eg, talking on the telephone or giving a speech or presentation. Swallowing concerns may be limited to mild difficulty with solid foods, eg, ''feels like the food gets stuck.'' More serious symptoms, such as nasal regurgitation of liquids and aspiration, are indicators of more advanced disease. Patients with MG who have difficulty chewing often describe progressively weaker chewing force with each successive bite. The difficulty is worse with solid foods, particularly meat. There is no associated pain, differentiating this complaint from jaw claudication due to temporal arteritis.
Rarely, patients with MG may present with respiratory muscle weakness without other prominent MG symptoms (Jani-Ascadi and Lisak, 2007) . However, the vast majority of patients with respiratory muscle weakness have ocular and bulbar concerns. Patients with diaphragmatic weakness will often have orthopnea as an early symptom. This may lead to respiratory compromise when the patient is placed in the supine position. Patients with MG and respiratory muscle weakness may report an inability to draw a full breath. They often describe their breathing as rapid and shallow, which may be misinterpreted as hyperventilation due to anxiety.
Fatigable extremity weakness in MG may affect any muscle group and may be asymmetric. Rarely, weakness may be very focal, affecting distal limb muscles (Nations et al, 1999) or neck extensors (D'Amelio et al, 2007) selectively. Characteristically, muscles are noted to weaken with repeated use, and strength improves with rest. Patients may note the development of a footdrop with prolonged walking, hip extension weakness with climbing several flights of stairs, shoulder muscle fatigue with activities that require holding the arms above the head, and weakness of finger flexors and extensors with prolonged typing. Symptoms may worsen with exposure to extreme heat or emotional stress. Infection, systemic illness, pregnancy, the menstrual cycle, or drugs that affect neuromuscular transmission may also exacerbate myasthenia. Patients may report that they plan activities for early in the day when their strength is at its peak. On the other hand, severe disease may cause prominent muscle weakness in which fatigability is not necessarily apparent.
Physical signs. The classic physical signs of MG include ptosis, ophthalmoparesis, bulbar weakness, and fatigable extremity weakness. Unfortunately, the clinical presentation in individual patients is often quite variable, and the diagnosis may be difficult. A history of fatigable weakness in specific muscle groups should prompt further investigation for a neuromuscular junction (NMJ) defect, regardless of whether clinical signs of weakness are observed on examination. In a patient with suspected MG, the following muscle groups should be specificallytested:facial,ocular,oropharyngeal, respiratory, axial, and limb muscles. The distribution of weakness in a large cohort of patients with MG (Grob et al, 2008 ) is given in Table 1 -2. All patients had some degree of detectable ocular muscle weakness, but only 17% had purely ocular involvement. The incidence of purely ocular and oculobulbar weakness was significantly higher in males compared with females in this cohort, while ocular with generalized weakness was more prevalent in females.
Ocular muscle weakness. The extraocular muscles and the eyelid elevators are involved to different degrees in individual patients with MG. Pupillary responses are normal. Eyelid ptosis is usually asymmetric and may vary considerably during the course of the examination. Ptosis is worsened with sustained upgaze. Resting the lids by having the patient close the eyes for 30 seconds may lessen the ptosis for a time. Patients with little or no ptosis at rest may develop ptosis after sustained upgaze for 60 to 180 seconds. Manual elevation of the more ptotic lid may worsen ptosis on the contralateral side, a phenomenon known as enhanced ptosis (Gorelick et al, 1981) . Finally, ptosis may improve in response to local cooling of the lid (Larner, 2004) . To compensate for ptosis, the frontalis muscle may be chronically contracted, and unilateral frontalis ''hypercontraction'' is a clue that the lid elevators are weak on that side.
The pattern of extraocular muscle weakness in MG is typically asymmetric and not isolated to the distribution of a single cranial (III, IV, VI) nerve. The pattern of weakness may fluctuate and change even during the course of a single examination. The medial rectus muscle is most frequently affected, followed by the superior and lateral rectus muscles. Rarely, weakness may be isolated to the lateral recti. Examination of extraocular movements should include a minimum of 15 to 30 seconds of lateral and superior gaze holding. The cover-uncover test may elicit mild weakness of a specific extraocular muscle by causing shifting fixation in the direction of action of the weak muscle. Sustained lateral gaze will produce fatigable weakness of the medial or lateral rectus muscles. With attempted lateral gaze, the adducting eye may not move, and the abducting eye may demonstrate nystagmus that becomes coarser as the lateral rectus muscle fatigues, a phenomenon called pseudointernuclear ophthalmoplegia. Sustained upgaze for 30 seconds is usually sufficient to produce weakness of the medial rectus muscles in MG. It is important to be aware that holding the stimulus for upgaze too close will elicit a failure of convergence alone that is not necessarily an abnormal finding. If diplopia or dysconjugate gaze is due to a failure of convergence alone, moving the target farther from the patient will improve the abnormality. Conversely, moving the target farther away will exacerbate the problem in MG and increase the apparent separation of the images. Facial muscles. Many patients with MG have a characteristic facial appearance. Facial weakness may produce a ''sagging'' appearance and loss of facial expression. Often, patients will elevate an eyebrow by contracting the frontalis muscle in an attempt to compensate for ptosis. With blinking or eyelid closure, the sclera may not be completely covered because of weakness of the orbicularis oculi muscle. Weakness of eyelid closure is seen in most patients with MG and should be specifically sought by asking patients to forcefully close their eyes while the examiner attempts to manually open the eyelids. Weakness of the orbicularis oris muscle may produce the characteristic horizontal or ''snarling'' appearance with attempts to smile. Patients may also have difficulty puffing their cheeks or pursing their lips. With attempts to purse the lips, a ''horizontal pucker'' is frequently observed because of the inability to approximate the sides of the mouth.
Oropharyngeal muscles. The dysarthria in MG is often characterized by nasal speech due to posterior pharyngeal weakness and articulation abnormalities with labial and lingual consonant and vowel distortion caused by facial and tongue weakness. Laryngeal weakness may cause speech output to be hypophonic (breathy, whispered, or hoarse). Again, these abnormalities are brought on (or worsened) by sustained talking. It is sometimes useful to ask MG patients with bulbar symptoms to count up to 50, and listen for the development of nasal speech and labial and lingual dysarthria.
Patients with dysphagia should be examined carefully for palatal weakness. The soft palate should be observed as the patient says ''Ah'' to make sure it rises normally in the midline. Weakness of the tongue muscles may also cause dysphagia because of abnormal movement of the bolus of food in the oral cavity. Tongue protrusion should be checked by having the patient protrude the tongue into the cheek while the examiner applies resistance on the outside surface of the cheek. Some experience is required to determine the amount of resistance to apply and the force of protrusion that is normal.
Patients with MG who have difficulty chewing usually give a revealing history as described above. When these patients are examined, weakness of jaw closure due to masseter and temporalis muscle weakness may be present. Weakness of jaw opening due to pterygoid muscle weakness, on the other hand, is rarely seen in MG even with relatively severe weakness of the masseter muscles. This pattern of weak jaw closure and relatively strong jaw opening is quite typical of MG. The masseter and temporalis muscles are checked by having the patient clamp the jaws together while the examiner attempts to separate them by applying downward pressure on the chin. It is best to sustain a moderate level of downward pressure for a period of 30 seconds rather than applying momentary pressure forcefully. The pterygoid muscles are evaluated by having the patient open the jaw while the examiner applies upward pressure below the chin.
Respiratory muscles. It is frequently difficult to reliably distinguish the status of the respiratory muscles from the functional status of the lungs themselves. However, simple observation is often quite revealing. Patients with respiratory muscle weakness due to MG often present with tachypnea and shallow breathing. They may be anxious because of an inability to draw Formal measurements of pulmonary function such as forced vital capacity may be useful but are also dependent on a number of factors, including pulmonary status. Results should be interpreted carefully in patients with MG, given the fluctuating nature of the disease. It is not uncommon for an MG patient with intermittent symptomatic dyspnea by history to have normal pulmonary function tests and bedside respiratory muscle strength parameters. The normal tests are reassuring but should not lead to the suggestion that the complaint is factitious or not potentially clinically relevant. Repeated testing of respiratory parameters will cause a worsening with each subsequent trial in MG patients with ventilatory muscle weakness and may exhaust the breathing muscles. Arterial blood gas measurements are a relatively insensitive measure of impending respiratory decompensation in MG since the initial changes are usually consistent with hyperventilation and may falsely be attributed to anxiety. By the time carbon dioxide retention occurs, the respiratory muscles have already begun to decompensate. MG patients with respiratory muscle weakness will often have weakness of neck flexion or extension, which may be a useful association if there is any doubt that the respiratory decompensation is due to myasthenic weakness.
Axial/limb muscles. Patients with MG may have weakness in many different patterns affecting the limb and axial muscles. Patients with mild disease may have weakness limited to the neck flexor muscles. Typically, neck flexion is weaker than neck extension in patients with MG, although occasionally patients will present with the ''dropped head syndrome'' and have severe neck extension weakness (D'Amelio et al, 2007) . Initial presentations with severe neck extensor muscle weakness have also been reported in MuSK-antibody-positive MG (Casasnovas et al, 2007) . Finger and wrist extensors and shoulder abductor muscles are most likely to be affected in the upper limb. In the lower extremity, the foot dorsiflexors and hip flexors are most frequently involved. Weakness is usually relatively symmetric, but may be asymmetric and even focal. At the author's institution, we have observed weakness of finger extension involving a single digit and asymmetric weakness of foot dorsiflexion resulting in a unilateral footdrop in patients with MG. Hand muscles, particularly finger extensors, appear to be involved more frequently than distal leg and foot muscles (Nations et al, 1999) .
Fatigable muscle weakness may be demonstrated by having patients sustain arm abduction for a period of time or by having them raise a leg at an angle of 308 to 408 while lying supine and maintain this position against gravity. Patients may be tested in this way until they fatigue, or the muscles may be manually tested after a period of 1 to 2 minutes of fatiguing exercise. Arising from a low chair without using the arms 10 to 20 times repeatedly is a good test for hip extensor muscle fatigue. AMYOTROPHIC LATERAL SCLEROSIS ALS is a progressive neurodegenerative disease of upper motor neurons (UMNs) and lower motor neurons (LMNs) that has both sporadic and inherited forms. It is a disease with no significant treatments that alter the disease course and a poor prognosis. It can be a difficult disease to diagnose since mimics of ALS exist, and clinical phenotypes are heterogeneous. Patients most often report progressive asymmetric weakness in the distal limbs. However, weakness may manifest in any body segment (bulbar, cervical, thoracic, or lumbosacral) and affect eating, swallowing, speaking, fine motor control, walking, and eventually breathing. Life expectancy on average is between 3 and 5 years from the date of diagnosis, with a shorter survival time for bulbar onset patients.
The hallmark of the clinical diagnosis of ALS is the presence of UMN and LMN signs (Table 1-3) coexisting in multiple body regions (cranial, cervical, thoracic, or lumbosacral) in the relative absence of sensory abnormalities. To date, no pathognomonic diagnostic test is available, and the diagnosis is entirely a clinical one. Patients with findings suggestive of ALS are typically assigned to differing levels of diagnostic certainty (suspected, possible, probable, and definite) based on a set of defined diagnostic criteria known as the El Escorial criteria. These criteria were established in 1991 for research purposes and were recently revised (Brooks et al, 2000) . A definite diagnosis of ALS requires the presence of UMN and LMN features in three or more body regions (cervical, thoracic, lumbosacral, and cranial). Probable ALS is classified as LMN and UMN signs in two regions, and probable ALS (laboratory supported) is classified as LMN and UMN signs in one region plus EMG evidence of acute denervation in two or more muscles in two or more limbs (Brooks et al, 2000) . These criteria have proved to be useful for the standardization of diagnostic criteria for clinical research studies. However, when it comes to the diagnosis of the patient in the earlier stages of the disease, these criteria may be too strict as many patients will not meet the criteria for definite or probable ALS at the time of presentation. A careful neurologic examination, however, even early in the course of the disease can aid in making the correct diagnosis. This section will give the examiner bedside tools for the examination of a patient with suspected ALS. As the diagnosis of ALS is a clinical one, and no one test can provide definitive confirmation, recognition of classic and variant presentations is critical. Diagnostic support Characteristic symptoms. Most patients with ALS will present with the chief concern of asymmetric weakness affecting a limb. The next most common initial presentation consists of oropharyngeal or bulbar weakness causing dysarthria or dysphagia (Traynor et al, 2000) . The remaining patients will present less typically with head drop, shortness of breath, fasciculations, or rarely, cognitive dysfunction. Typically, symptoms have been present and progressively worsening for months when the patient initially presents for evaluation. Patients may have difficulty precisely dating the onset of symptoms but will usually recall vague symptoms of fatigue, clumsiness, loss of hand dexterity, etc, prior to the onset of frank weakness and/or atrophy. These initial symptoms may be discounted and often attributed to aging. Some patients have a rapidly progressive course with survival of less than 1 year from the onset of symptoms, while other patients progress much more slowly, far outliving the 5-year life expectancy.
Muscle fasciculations in the limbs and torso are almost a universal feature of ALS but may also be seen in other disorders affecting the motor neurons and may be experienced in the normal population as well. In ALS, fasciculations, unless profuse, often go unnoticed by the patient. In fact, the patient's spouse or partner may notice the fasciculations before the patient does. Muscle cramping is a common symptom in ALS and motor neuron disorders in general. Cramps may be quite painful and bothersome and occur after contraction of the involved muscle or at rest. Muscle cramps may be particularly bothersome when they involve a non-limb muscle such as the jaw or trunk muscles. Often cramping is precipitated by an ordinary contraction or a change in muscle length. For example, a yawn can precipitate a painful jaw cramp, or a simple twisting movement of the torso can precipitate muscle cramps involving the trunk. The cramping tends to be more severe during the early stages of the disease when reinnervation is prominent and tends to subside when muscles become very weak and atrophic. Paroxysmal laryngospasm may be thought of as a cramp affecting the laryngeal muscles and tends to be a very anxietyproducing symptom for patients. When the spasm occurs, the patient cannot draw a breath and appears to be choking. The spasm typically subsides within several seconds, but the involuntary nature and the unpredictability of the spasm leads to an understandable feeling of panic.
Sialorrhea is caused by progressive weakness of oral, lingual, and pharyngeal muscles and is a frequent and embarrassing problem in ALS patients with bulbar symptoms. Pseudobulbar emotional lability can coexist with other UMN signs involving the bulbar muscles. This manifests as excessive uncontrollable or uncharacteristic laughing or crying.
Physical signs. All patients with suspected ALS should be observed for the presence of fasciculations. This absolutely requires that the patient disrobe since fasciculation may be most prominent in the torso, periscapular region, and proximal thigh. Unlike benign fasciculations, which typically are infrequent and tend to involve one motor unit causing recurrent twitching of the same muscle or group of muscle fibers, fasciculations in ALS generally occur in multiple motor " SUSPECTED MYASTHENIA GRAVIS OR ALS units simultaneously and continuously. When present in this pattern, they aid in the diagnosis of ALS as they can be considered an LMN finding in the body region where they are observed. Fasciculations are not invariably present in ALS at all stages of disease, however, and they may not be visible in some patients. In other patients, very close observation is needed to adequately detect the presence of fasciculations. On the other hand, the patient who presents with a report of profuse and constant muscle twitching, but on examination has no observable fasciculations, almost invariably does not have ALS but likely has a benign fasciculation syndrome.
A classic sign in ALS is tongue fasciculations, and the differential diagnosis of tongue fasciculations is given in Table 1 -4. It is not unusual for the normal tongue to exhibit tremulous movements upon protrusion or with maintaining the tongue in a certain position. These movements should not be confused with tongue fasciculations. When tongue fasciculations are present, they are generally quite obvious and have a characteristic multifocal distribution involving the entire tongue and the appearance of small wriggling or dimpling under the tongue surface. Observation of the tongue for the presence of fasciculations may be aided either by having the patient open the mouth as widely as possible while allowing the tongue to rest on the floor of the mouth or by having the patient protrude the tongue outside the mouth and then gently bite down on it, allowing the examiner to inspect the outer aspects of the tongue. Tongue fasciculations are typically present in ALS when there is LMN degeneration involving the tongue muscle, and they are usually associated with varying degrees of tongue weakness and atrophy. Weakness of the tongue may be present without fasciculations if bulbar weakness is due to UMN degeneration.
Weakness of the tongue is an extremely useful sign in ALS, as useful as tongue fasciculations, and probably more reliable. Weakness of the tongue in ALS can best be assessed by having the patient protrude the tongue into the cheek and hold it there while the examiner applies resistance from outside the cheek. The tongue weakness in ALS tends to be symmetric. Some ALS patients with advanced bulbar disease cannot move their tongue voluntarily at all. However, it is possible to have moderately advanced disease without significant tongue involvement if the patient has mostly spinal disease. In bulbar disease with a prominent UMN component, tongue bulk and the strength of tongue protrusion may appear to be normal. These patients will exhibit difficulty quickly moving the tongue side to side or into and out of the mouth because of UMN dysfunction. Although facial weakness is not classically considered to be a characteristic sign in ALS, it may be present, particularly in more advanced disease. The finding of facial weakness in ALS is potentially helpful because one of the important differential diagnoses of ALS is cervical spinal stenosis, and clinical findings above the neck, such as facial weakness, tongue weakness, or dysarthria, can rule out this possibility. As in MG, the facial weakness in ALS tends to be symmetric, but unlike MG, in most cases, it is not present until later in the disease course. One way to test lower facial muscle strength is to have the patient puff out the cheeks. Normally, one should be able to hold some resistance to this maneuver. For upper facial weakness, squeezing the eyes tightly shut while the examiner attempts to open the lids is another helpful bedside test. More severe facial weakness and characteristic facial fasciculations in a patient with a more chronic disease course suggest the diagnosis of X-linked bulbospinal neuronopathy (see the chapter ''Clinical Spectrum of Motor Neuron Disorders'').
The presence of pathologic reflexes such as hyperactive muscle stretch reflexes, Hoffmann sign, Babinski sign, and crossed adductor reflexes can aid in the diagnosis of ALS, especially when LMN signs such as atrophy or fasciculations are located in the same body region. Relative preservation of reflexes (nonpathologic) in the distribution of severe muscle weakness and atrophy is also a sign of UMN dysfunction. A hyperactive gag reflex, an increased jaw jerk, or a positive snout reflex can help to localize UMN dysfunction above the cervical spinal cord.
Limb weakness. Unlike in MG where limb weakness usually affects proximal muscles relatively symmetrically, the limb weakness in ALS can present in any muscle group, but more commonly presents distally and asymmetrically in a limb, eg, with a weak and atrophic hand or footdrop. Weakness in ALS is segmental, meaning that muscles belonging to the same myotome and innervated by the same pool of motor neurons are affected similarly. The disease may initially start focally in one or two myotomes, a pattern that may mimic a radiculopathy clinically and electrodiagnostically, except for the relative absence of pain and sensory symptoms. A further discussion of the characteristics of limb weakness in ALS appears later in this chapter.
Respiratory muscle weakness. ALS affects the diaphragm and intercostal muscles, and weakness in these muscles is obviously of critical importance. Orthopnea or dyspnea with exertion is typically the initial symptom of respiratory muscle weakness in ALS. However, respiratory muscle compromise is often present before the patient becomes overtly symptomatic, presenting with nocturnal oxygen desaturations, daytime fatigue, or sleep disturbances. Some patients never feel short of breath despite significant ventilatory compromise, especially if the ventilatory impairment has been more slowly progressive.
Examination of respiratory muscle function at the bedside consists of having the patient perform an inspiratory sniff and cough as a test of inspiratory and expiratory muscle function respectively. Protrusion of the abdomen against resistance may also be helpful as a rough bedside indication of diaphragmatic strength as described in the previous sections for MG. Bedside measurement of forced vital capacity is commonly used in most multidisciplinary ALS clinics as an indicator of diaphragmatic function. This test is more reliable than it is in MG since in ALS, diaphragmatic weakness is not likely to fluctuate, and ALS patients are less likely to have significant facial weakness, at least in the earlier stages. Occasionally, patients with ALS are diagnosed only after they are unable to be weaned from a ventilator. This unfortunate situation may occur for the patient who presents with more focal diaphragmatic weakness or occasionally in the elderly patient whose weakness or walking difficulties are dismissed as features of old age. Right heart failure can develop from untreated respiratory failure and is generally a late finding. Lower extremity edema, however, may occur as a result of venous stasis (dependent edema in a weak limb) or from right heart failure.
Bulbar (oropharyngeal) weakness. Involvement of bulbar muscles in ALS produces dysarthria, dysphagia, and sialorrhea. When UMN involvement is present, the patient has slow speech and spastic dysarthria, increased jaw jerk, normal-appearing but weak or slow tongue, pseudobulbar laughing or crying, and pathologic reflexes such as an increased jaw jerk, hyperactive gag reflex, or a snout reflex. With LMN involvement, the patient may have flaccid dysarthria, as well as weakness, atrophy, and fasciculations of the tongue. Typically both UMNs and LMNs are involved, producing a mixed spastic and flaccid dysarthria. A discussion contrasting the features of dysarthria and dysphagia due to ALS and MG can be found later in this chapter.
Cognitive impairment and behavioral changes. Although the degenerative process in ALS predominantly affects the motor system, cognitive and behavioral symptoms have been described in patients with ALS for some time. Some degree of cognitive impairment may occur in as many as 22% to 35% of patients with ALS. Frontotemporal dementia is associated with ALS in approximately 3% to 5% of cases (Lomen-Hoerth et al, 2004). In most patients, the cognitive impairment manifests as mild frontal lobe dysfunction that may lead to poor judgment, difficulty with problem solving, and inattention, while memory and praxis remain relatively intact (Murphy et al, 2007) . Patients may display disinhibited behavior, obsessive-compulsive behavior, or may become withdrawn and disinterested. Often, in milder cases of cognitive changes, the patient and family are unaware of any impairment. Speech dysfunction often coexists with the cognitive impairment, thus making the recognition of the cognitive change more difficult.
Truncal weakness. Weakness in ALS may affect the thoracic body region or core muscles. The signs and symptoms of this may include difficulty keeping the body erect, difficulty sitting up in bed, incoordination, and even pelvic floor weakness. Occasionally loss of core muscle strength can lead to an apparent gait imbalance because of an inability to stabilize the core muscles while walking. This may mislead the unwary clinician to suspect coexistent primary cerebellar dysfunction, but in ALS there are no additional signs of cerebellar dysfunction such as limb ataxia or nystagmus. Additional signs of truncal involvement may include absent superficial abdominal reflexes and fasciculations on the abdomen and back.
History of weight loss. Weight loss is a very common symptom in ALS. Weight loss may occur on the basis of malnutrition caused by severe swallowing difficulties and loss of dexterity in the upper limbs. Loss of appetite leading to cachexia can occur when respiratory dysfunction is present. Loss of muscle mass due to denervation atrophy may also contribute to the weight loss in some patients. Finally, a state of hypermetabolism has been described in patients with ALS. The origin of this hypermetabolic state is uncertain, but it may occur in as many as 50% of patients with ALS (Desport et al, 2005) .
Mild sensory symptoms. A hallmark of ALS is the relative absence of sensory symptoms and findings. A recent report, however, indicates that about one-third of patients with ALS report some mild sensory symptoms (Hammad et al, 2007) . This is generally in the form of mild distal sensory loss. Often the symptom will be present, but the sensory examination will be entirely normal. Sural sensory conduction studies may be abnormal in approximately the same proportion (one-third) of patients, and in the study of Hammad and colleagues (2007) a pathologic loss of large myelinated fibers was observed in over 90% of patients who had sural nerve biopsies. It is unclear whether these findings are the result of normal aging processes or whether there is a true association with the underlying degenerative process.
DISTINGUISHING FEATURES OF ALS AND MYASTHENIA GRAVIS ON CLINICAL PRESENTATION
The most common presenting symptoms in MG are double vision (or blurred vision) and ptosis. Ocular findings such as these clearly distinguish MG from ALS, as the ocular muscles are spared in ALS. However, when double vision and ptosis are not clearly present, making the correct diagnosis may be a bit more challenging as illustrated by Cases 1-1 and 1-2. Additionally, 10% to 15% of patients with MG will be anti-acetylcholine receptor (AChR) negative, and up to 60% of these patients will also be MuSK-antibody negative (see the chapter ''Myasthenia Gravis: Immunopathogenesis, Diagnosis, and Management''), often leaving the diagnosis in question. Both ALS and MG may present with dysarthria and/or dysphagia, fatigability, and limb or axial weakness. Clinical clues that can help to accurately determine the cause of these symptoms and signs as caused by ALS, MG, or some other disorder are presented later in this chapter.
Prominent Dysarthria/Dysphagia
Patients presenting with reports of dysarthria and/or dysphagia may have central or peripheral nervous system disease. The neurologic differential diagnosis for this complaint is long ( (Llabres et al, 2005) . The presentation will typically have a fatigable component while the dysarthria and dysphagia in ALS are typically nonfluctuating and progressive. Early in the course of ALS, however, the patient may describe a fluctuating history with the dysarthria being more pronounced at the end of the day or after prolonged talking. As time goes by, the speech
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Case 1-1
A 57-year-old woman presented reporting an inability to lift her head off her chest and shortness of breath with exertion for the past 4 to 5 months. She had no significant medical history. She denied double vision or blurred vision, droopy eyelids, speech or swallowing difficulties, or limb weakness. She was diagnosed with MG at an outside institution after an edrophonium (Tensilon) test and was reportedly responding to pyridostigmine treatment (60 mg every 6 hours) with a subjective improvement in neck strength and breathing. Recently, however, the pyridostigmine was noted to be less effective. Anti-AChR-binding antibodies were reportedly negative. Repetitive nerve stimulation (RNS) performed in a hand muscle and on the trapezius muscle was normal, but single fiber EMG (SFEMG) performed on the extensor digitorum communis muscle showed an increased mean jitter. MRI of the cervical spine showed mild disc bulges and osteophytes at several levels but no evidence of cord or nerve root compression.
Physical examination revealed a respiratory rate of 12 breaths per minute, a normal mental status, and normal cranial nerve function with the exception of a head drop with neck extensor strength graded at 3/5 and neck flexor strength graded at 4-/5. She had mild symmetric weakness (4+) in arm abduction, but otherwise her limbs were strong. Her reflexes were 2+ and symmetric throughout, and her sensory and gait examinations were normal. Repeat EMG was performed to clarify the diagnosis. Nerve conduction studies (NCS) were normal, but conventional needle EMG showed fibrillation and fasciculation potentials in multiple proximal and distal upper extremity muscles, in the sternocleidomastoid muscle, and in the thoracic paraspinal muscles. Motor unit action potentials in the upper extremity muscles were variable; some showed a normal appearance and others had long duration, increased amplitude, and polyphasia, consistent with reinnervation. The results were interpreted as showing evidence of a multisegmental motor neuronopathy and were felt to support the clinical diagnosis of ALS.
Comment. This patient presented with a head drop and exertional dyspnea, which are symptoms that could be associated with various neuromuscular disorders (Table 1-8). She was mistakenly thought to have MG on the basis of a ''positive'' edrophonium test and abnormal SFEMG. Repeat studies, however, showed abnormalities on conventional needle EMG that were consistent with motor neuron disease. A response to edrophonium or even pyridostigmine may be misleading in cases of ALS, particularly early in the disease course. This patient appeared to respond initially, at least subjectively, to treatment with cholinesterase inhibitors despite having ALS. Similarly, an abnormal SFEMG can also be misleading in cases where conventional EMG is not performed, with a failure to diagnose primary nerve or muscle disease causing secondary NMJ dysfunction. A In ALS, there is usually a spastic quality to the speech. Therefore, the speech is slow, effortful, and has a harsh or ''strangled'' vocal quality.
difficulty will become more prominent and consistently present with less of a fluctuating nature. The dysarthria in MG typically maintains its fatigable and fluctuating character throughout the course of the disease. It is more typical for a patient with ALS than a patient with MG to present with isolated Case 1-2
A 74-year-old man with a diagnosis of MG was transferred from an outside facility for further management. He was in his usual state of health until 2 months previously. At that time, he developed dysphagia and shortness of breath. He was admitted to an outside hospital where he required intubation and ventilation. AChR antibodies were reported as positive by the outside hospital. RNS studies reportedly showed an abnormal decrement to 3-Hz stimulation in a hand muscle and a superimposed cervical radiculopathy. Prior to his transfer, he had been treated with pyridostigmine 30 mg twice daily and had received five plasmapheresis treatments. He was successfully extubated shortly after completion of plasmapheresis. He was subsequently treated with a course of IV immunoglobulin treatments, prednisone 60 mg daily, and mycophenolate mofetil 750 mg twice daily. Despite these treatments, his respiratory status declined, and he had recently undergone tracheostomy and percutaneous endoscopic gastrostomy tube placement.
On physical examination, the patient was awake and alert and ventilated through a tracheostomy. His cranial nerve examination showed normal extraocular muscle strength and normal facial strength. There was no ptosis. He had mild tongue weakness and clearly visible tongue fasciculations. He was not able to lift his head off the pillow. He had asymmetric shoulder girdle weakness, more severe on the right compared with the left. Distal upper extremity strength, including finger extension, was normal. His hip flexion was mildly weak bilaterally. He had right foot dorsiflexion weakness (4-/5). Fasciculations were observed in the anterior chest, right upper arm, and right thigh. Reflexes were asymmetric: 2+ on the right and 3+ on the left. Needle EMG and NCS were performed showing normal motor and sensory NCS as well as normal RNS studies in the sternocleidomastoid muscle. Needle EMG showed positive waves, fibrillations, and fasciculation potentials in multiple proximal and distal muscles of the right arm and leg and in the rectus abdominus muscle. Multiple muscles showed motor unit potentials, which were large in amplitude and duration with polyphasia.
Upon further investigation, the patient's ''seropositivity'' had been based on elevated AChR-blocking antibody titers, which when repeated were found to be in the normal range. Anti-AChR-binding antibody titers were not elevated. He was diagnosed with ALS.
Comment. This patient was mistakenly diagnosed with MG based on ''positive antibodies.'' Since the AChR-blocking and AChR-modulating antibody tests are not as widely used for the diagnosis of MG, their specificity is uncertain. AChR-blocking antibodies most frequently are found in patients with anti-AChR-binding antibodies and are present in isolation only 1% of the time. This finding should have been repeated or another means of diagnostic confirmation should have been sought. A thorough clinical and electrodiagnostic evaluation, not even requiring RNS or SFEMG, would have established the diagnosis in this case.
KEY POINT
A In MG, the dysarthria is typically flaccid and hypernasal with lingual and labial dysfunction.
bulbar findings because of the segmental nature of the disease. For ALS, the term progressive bulbar palsy is often used to describe patients who present in this way.
In MG, generally other clinical clues, such as ptosis, diplopia, or fatigable weakness in the setting of normal reflexes and normal muscle bulk, can often lead to the diagnosis. An important clue to distinguish dysarthria associated with MG from that of ALS is the character of the dysarthria itself (Table 1-6). For example, patients with ALS, generally speaking, have a distinctive dysarthria with a combination of spastic and flaccid qualities.
Bilateral damage of the UMNs of the pyramidal tracts imparts a spastic quality to the speech. Therefore, the speech is slow and effortful and has a harsh or ''strangled'' vocal quality. The patient with ALS may also display slow arduous movements of the tongue in addition to tongue weakness. Tongue atrophy and fasciculations may or may not be present in the ALS patient with tongue weakness, depending on the degree of UMN versus LMN involvement. In contrast, in MG the dysarthria is flaccid, and myasthenic speech often has a nasal quality resulting from the presence of palatal weakness. There is no spastic quality to the speech as the UMN is not involved in MG. The speech is slurred in MG, but generally the cadence is normal, and patients with MG do not show tongue atrophy or fasciculations. Patients with MG may have tongue protrusion weakness but do not show the slow arduous tongue movements seen in ALS.
Dysphagia may be a presenting symptom in MG and ALS, and distinguishing features of the dysphagia seen in these two disorders are given in Table 1 -7. An early symptom of dysphagia due to pharyngeal weakness in ALS is the inability to effectively clear the throat of mucus. Often patients will describe a nagging feeling that phlegm is stuck in the throat and they cannot clear it. Some patients may refer to this as a ''tickle'' in the throat. In contrast, this is not a common symptom in MG. More commonly, patients with MG will have a tendency to regurgitate through the nose because of palatal weakness or into the oral cavity from upper esophageal weakness (Colton-Hudson et al, 2002) . Limb weakness in ALS can occur in any muscle group, but the most common presentation of limb weakness in ALS is asymmetric distal limb weakness. For example, weakness and wasting of intrinsic hand muscles (both median-innervated and ulnar-innervated muscles) in a unilateral or asymmetric fashion is a typical presentation. Alternatively, footdrop is also a common presentation. Footdrop in ALS can be distinguished from peroneal mononeuropathy or lumbar radiculopathy by the lack of associated pain or sensory symptoms. There is also usually weakness outside of the peroneal or L4-5 distribution, UMN reflex changes, or more widespread changes on EMG than would be suspected with a mononeuropathy or isolated lumbar radiculopathy.
Head Drop

Bowel and Bladder Function
In most instances, bowel and bladder function are spared in ALS and MG. However, despite the fact that the classic teaching is that bowel and bladder function are spared in ALS, urinary urgency and dribbling are not uncommon in patients with ALS who have a spastic paraparesis as well as in patients with pelvic floor weakness. Frank incontinence, however, is generally not present until late in 
Fatigue
Motor fatigue is a common complaint in patients with ALS, but it is usually not included in the clinical assessment of these patients. The etiology of fatigue in these patients is most often attributed to unstable neuromuscular transmission in reinnervating NMJs, but other causes may be relevant. Higher firing rates of surviving motor axons attempting to compensate for the loss of motor neurons may be a likely explanation for the activitydependent dysfunction in ALS (Vucic et al, 2007) . It is also likely that central factors contribute to the complaints of fatigue in ALS.
Compared with the fatigability reported by patients with MG, patients with ALS more often report general fatigue that has both physical and psychological components. Patients with ALS also frequently report excessive daytime somnolence, which may be an indicator of nocturnal hypoventilation. Earlier in the disease course, when dysfunction is limited to a particular body region or myotome, patients with ALS may have true fatigable muscle weakness with symptoms that worsen with use of the affected muscle and improve with rest. This pattern may occasionally be seen in patients with initially isolated bulbar palsy, making the clinical distinction from MG difficult.
PITFALLS IN THE DIAGNOSTIC TESTING OF MYASTHENIA GRAVIS AND ALS
Electrodiagnostic Testing in Myasthenia Gravis RNS studies and SFEMG are the electrodiagnostic tests used to confirm the presence of a defect in neuromuscular transmission in MG. However, emphasis should be placed on the importance of performing conventional needle EMG and sensory and motor NCS in patients suspected of MG before proceeding to more specialized tests. This is because RNS and SFEMG abnormalities are relatively nonspecific. Other primary disorders affecting the nerve or motor neuron and even muscle may show abnormalities on RNS and/or SFEMG that may be mistaken for MG. For example, abnormal decremental responses on RNS and increased jitter on SFEMG may both be present in patients with motor neuron disease (Case 1-1). As noted, this is explained by the fact that in motor neuron disease, reinnervating NMJs have impaired neuromuscular transmission because of the immaturity of the reinnervating nerve terminal. In a more rapidly evolving motor neuron disease such as ALS, a higher number of NMJs probably are either actively reinnervating or recently denervated, increasing the likelihood of finding a secondary defect of neuromuscular transmission. In MG, however, the conventional NCS and EMG studies are normal, while in primary neurogenic or myopathic conditions, the conventional NCS and EMG reveal the primary abnormality. In addition, increased jitter on SFEMG testing will be accompanied by the finding of increased fiber density in ALS, while fiber density will be normal in MG.
Electrodiagnostic Testing in ALS
As stated previously, ALS is a clinical diagnosis, and no specific laboratory or imaging test can absolutely confirm or refute the diagnosis. The utility of electrodiagnostic testing, including EMG, in providing supportive evidence in favor of the diagnosis has been affirmed (de Carvalho et al, 2008) , but the results of this testing must always be interpreted in the context of the clinical presentation. See Table 1 -11. In the context of ALS, electrodiagnostic testing can favor the diagnosis of ALS by showing multisegmental active denervation (denervation in cranial, cervical, thoracic, and/or lumbosacral body regions) that localizes proximal to the dorsal root ganglia, ie, sparing sensory nerve conduction potentials. Recent recommendations advocate attributing equivalent significance to fasciculation potentials as fibrillation potentials in recognizing denervation (de Carvalho et al, 2008) . These findings are not specific for ALS as polyradiculopathy may have the same electrodiagnostic appearance. In early spinal ALS, EMG abnormalities may mimic those of a focal radiculopathy, and multisegmental denervation may not be apparent until later in the disease course. Also, in the case of bulbar-restricted ALS, the EMG may be normal or near normal. This is especially true if the patient's bulbar symptoms are predominantly caused by UMN degeneration. In this case, even EMG of the tongue may not show clear abnormalities. EMG of the sternocleidomastoid muscle has a similar sensitivity compared to the tongue in patients with bulbar symptoms and should be examined if the tongue is normal. It is important to keep in mind, however, that an abnormal EMG in a cranialinnervated muscle may also be caused by a structural or infiltrating lesion of the lower brainstem, which should be investigated with the appropriate neuroimaging studies.
EMG is most helpful in the diagnosis of ALS when asymptomatic body regions show abnormalities that add to the distribution of LMN dysfunction demonstrated clinically. It is recommended, therefore, that cranial, cervical, thoracic, and lumbosacral body regions be thoroughly investigated (generally unilateral is sufficient) in all patients with suspected ALS.
Acetylcholinesterase Inhibitors
A clinical response to edrophonium or to treatment with pyridostigmine 
